Fondation Ophtalmologique Adolphe De Rothschild

This phase 3 trial tests whether people with active multiple sclerosis who have been stable on Ocrevus for at least two years can safely switch to annual infusions instead of the standard every-6-month schedule. The goal is to see if the less frequent dosing is just as good at pr…

Researchers are testing whether adding glenzocimab to standard endovascular therapy improves recovery in adults with acute ischemic stroke caused by a large blocked vessel and a large area of brain damage. Participants receive either glenzocimab or a placebo as an intravenous inf…

This study looks at whether platelet activation in the blood is higher in people whose brain aneurysm has already burst compared to those with an unruptured aneurysm. Researchers will collect blood samples from 230 patients during treatment. The goal is to see if platelet activit…

This study follows 400 people who had a brain aneurysm rupture and were treated with a procedure called embolization. The goal is to learn about their long-term recovery and whether the aneurysm can come back. Researchers will track neurological outcomes using a standard scale. T…